Bupropion

Drug

Drug Profile

Bupropion is an atypical antidepressant also used for smoking cessation support and seasonal affective disorder. It is a norepinephrine-dopamine reuptake inhibitor and is marketed under brands including Wellbutrin and Zyban. The medicine is prescription-only and has been in U.S. clinical use since the 1980s.

Drug Class
Norepinephrine-dopamine reuptake inhibitor (NDRI) antidepressant
Approval Status
First approved for medical use in the United States in 1985; prescription-only
Mechanism of Action
Acts primarily as a norepinephrine-dopamine reuptake inhibitor and nicotinic receptor antagonist
Brand Names
  • Wellbutrin
  • Zyban
Indications
  • \Major depressive disorder\
  • \Seasonal affective disorder\
  • \Smoking cessation support\

Related News

Related Clinical Trials

NCT ID Title Status Phase
NCT07596212

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

NOT_YET_RECRUITING PHASE1/PHASE2
NCT07584434

A Phase 1, First-in-human Study of VX-433

NOT_YET_RECRUITING PHASE1
NCT07235748

Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

COMPLETED PHASE1
NCT07223671

Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants

COMPLETED PHASE1
NCT06973005

A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants

COMPLETED PHASE1
NCT06679413

A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants

COMPLETED PHASE1
NCT06564441

A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity

COMPLETED PHASE1
NCT06374290

Study of Injectable Naltrexone and Oral Bupropion Among Cigarette Smokers With Schizophrenia

TERMINATED PHASE1
NCT06367153

A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the Blood

COMPLETED PHASE1
NCT06254001

Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects

RECRUITING PHASE4